References
- Everhart J E. Summary. Digestive diseases in the Unites States: epidemiology and impact. U.S. Department of Health and Human Services, Public Health Service National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, J E Everhart. U.S. Government Printing Office, 1994: NIH publication, Washington, DC 1994; 1447: ix–xii
- Eisenberg D M, Kessler R C, Foster C, Norlock F E, Calkins D R, Delbanco T L. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993; 328(4)246–52
- Everhart J E. Summary. Digestive diseases in the Unites States: epidemiology and impact. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, J E Everhart. U.S. Government Printing Office, 1994: NIH publication, Washington, D.C. 1994; 1447: 55–82
- Drossman D A, Li Z, Andruzzi E, Temple R D, Talley N J, Thompson W G, et al. U.S householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993; 38(9)1569–80
- Hunt R H. Quality of Life—the challenges ahead. Scand J Gastroenterol Suppl 1993; 199: 2–4
- Sandler R, et al. A primer on outcomes research for the gastroenterologist: report of the American Gastroenterological Association task force on outcomes research. Gastroenterology 1995; 109: 302–6
- Edelson J T, Tosteson A N, Sax P. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding. JAMA 1990; 264(1)41–7
- Sonnenberg A, Townsend W F. Preoperative testing for fecal occult blood: a questionable practice. Am J Gastroenterol 1992; 87(10)1410–7
- Rex D K, Mark D, Clarke B, Lappas J C, Lehman G A. Flexible sigmoidoscopy plus air-contrast barium enema versus colonoscopy for evaluation of symptomatic patients without evidence of bleeding. Gastrointest Endosc 1995; 42(2)132–8
- Marwick C. Another healthcare idea: disease management. JAMA 1995; 274(18)1416
- Silverstein M D, Petterson T, Talley N J. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996; 110: 72–83
- Dusheiko G M, Roberts J A. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology 1995; 22(6)1863–73
- Rudolph Bedford M. D. Section Head. UCLA Division of Digestive Diseases Pancreatobiliary Section (personal communication).
- Irvine E J. Quality of Life—rationale and methods for developing a disease-specific instrument for inflammatory bowel disease. Scand J Gastroenterol. 1993; 28 Suppl 199: 22–7
- Fullerton S. Health-related Quality of Life. Curr Opin Gastroenterol 1996; 12, (in press)
- Drossman D A, Li Z, Toner B B, Diamant N E, Creed F H, Thompson D, et al. Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci 1995; 40(5)986–95